Search

Author/Creator Sandin, Fredrik

24. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era. (27th March 2015)

Authors:
Gunnarsson, Niklas; Stenke, Leif; Höglund, Martin; Sandin, Fredrik; Björkholm, Magnus; Dreimane, Arta; Lambe, Mats; Markevärn, Berit; Olsson‐Strömberg, Ulla; Richter, Johan; Wadenvik, Hans; Wallvik, Jonas; Själander, Anders
Journal:
British journal of haematology
Issue:
Volume 169:Number 5(2015:Jun.)
Page Start:
683
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry. (30th March 2021)

Authors:
Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; Dremaine, Arta; Lübking, Anna; Markevärn, Berit; Myhr‐Eriksson, Kristina; Olsson, Karin; Olsson‐Strömberg, Ulla; Själander, Anders; Söderlund, Stina; Wennström, Lovisa; Wadenvik, Hans; Stenke, Leif; Höglund, Martin; Richter, Johan
Journal:
British journal of haematology
Issue:
Volume 193:Number 5(2021)
Page Start:
915
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. (1st February 2018)

Authors:
Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina; Beskow, Anna; Ahlström, Håkan; Bill-Axelson, Anna; Birgisson, Helgi; Björ, Ove; Edqvist, Per-Henrik; Hansson, Tony; Helleday, Thomas; Hellman, Per; Henriksson, Kerstin; Hesselager, Göran; Hultdin, Magnus; Häggman, Michael; Högl...
Journal:
Acta oncologica
Issue:
Volume 57:Number 2(2018)
Page Start:
187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗